Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Inflammatory Breast Cancer
- Stage IIA Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Triple-negative Breast Cancer
- Stage IIB Breast Cancer
- Estrogen Receptor Negative
- Progesterone Receptor Negative
- HER2/Neu Negative
Interventions
- DRUG: carboplatin
- DRUG: paclitaxel albumin-stabilized nanoparticle formulation
- OTHER: laboratory biomarker analysis
Sponsor
City of Hope Medical Center
Collaborators